Contract Manufacturing Services

How robust is your strategy? Are you prepared for supply chain interruption?

Determining full versus empty capsids remains a key challenge with adeno-associated viral vectors.

As new treatment modalities emerge, drug developers are turning to synthetic chemistry – and partners like Veranova.

How one CDMO navigated the pandemic and came out on top of industry trends

Cell and gene therapy manufacturers need to make better plasmid design decisions with commercialization in mind.

We sit down with Akhil Ravi, CEO of Aurigene Pharmaceutical Services, to learn about his career and passion for the industry.

PCI has focused on becoming a trusted CDMO partner by building strong working relationships with clients.

African vaccine production needs a boost. Here’s how Aspen is working to make that happen.

Driven by the success of COVID-19 vaccines, mRNA products are expanding drug developers’ pipelines.

Reconfigure. Redefine. Why modular cleanroom furniture is essential for a changing pharmaceutical market.